BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1392 related articles for article (PubMed ID: 8751105)

  • 1. Panophthalmitis with acute scleral necrosis after brachytherapy of a malignant melanoma of the ciliary body.
    Bodanowitz S; Strempel I; Wiegand W; Kroll P
    Ger J Ophthalmol; 1995 Nov; 4(6):380-2. PubMed ID: 8751105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-onset scleral necrosis after iodine I 125 plaque radiotherapy for ciliochoroidal melanoma.
    Corrêa ZM; Augsburger JJ; Freire J; Eagle RC
    Arch Ophthalmol; 1999 Feb; 117(2):259-61. PubMed ID: 10037576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corneoscleral necrosis after episcleral Au-198 brachytherapy of uveal melanoma.
    Chaudhry IA; Liu M; Shamsi FA; Arat YO; Shetlar DJ; Boniuk M
    Retina; 2009 Jan; 29(1):73-9. PubMed ID: 18728617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scleral necrosis after plaque radiotherapy of uveal melanoma: a case-control study.
    Kaliki S; Shields CL; Rojanaporn D; Badal J; Devisetty L; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2013 May; 120(5):1004-11. PubMed ID: 23347983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
    Toivonen P; Kivelä T
    Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Block resection with scleral flap rotation in ciliary body melanoma].
    Romanowska-Dixon B
    Klin Oczna; 2005; 107(10-12):681-3. PubMed ID: 16619819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ruthenium plaque radiation for iris and iridociliary melanomas: development of dry eyes?
    Razzaq L; de Keizer RJ
    Br J Ophthalmol; 2010 Nov; 94(11):1549-50. PubMed ID: 20516146
    [No Abstract]   [Full Text] [Related]  

  • 10. [Homolateral episcleral metastasis or surgical seeding of a proton-irradiated ciliary body melanoma?].
    Daicker B; Zografos L; Müller O
    Klin Monbl Augenheilkd; 1988 May; 192(5):579-81. PubMed ID: 2841533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irido-cilio-choroidal melanoma in a 5-year-old boy treated by Ru-106 brachytherapy.
    Pe'er J; Averbukh E; Frenkel S
    Clin Exp Ophthalmol; 2009 Sep; 37(7):742-3. PubMed ID: 19788674
    [No Abstract]   [Full Text] [Related]  

  • 12. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic disease, eye retention and visual function in conservative treatment of uveal melanoma.
    Bornfeld N; Chauvel P; Sauerwein W; Friedrichs W; Tiburtius T; Wessing A; Foerster MH
    Front Radiat Ther Oncol; 1997; 30():97-110. PubMed ID: 9205890
    [No Abstract]   [Full Text] [Related]  

  • 14. Histopathologic findings in large uveal melanomas after brachytherapy with iodine 125 ophthalmic plaques.
    Schilling H; Bornfeld N; Friedrichs W; Pauleikhoff D; Sauerwein W; Wessing A
    Ger J Ophthalmol; 1994 Aug; 3(4-5):232-8. PubMed ID: 7804109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
    Heindl LM; Lotter M; Strnad V; Sauer R; Naumann GO; Knorr HL
    Ophthalmologe; 2007 Feb; 104(2):149-57. PubMed ID: 17123048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of ciliary body melanoma with iodine-125 plaque brachytherapy.
    Krema H; Simpson ER; Pavlin CJ; Payne D; Vasquez LM; McGowan H
    Can J Ophthalmol; 2009 Aug; 44(4):395-400. PubMed ID: 19606159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impression cytology of the conjunctiva following high-dose brachytherapy of malignant melanoma of the uvea using 106Ru/106Rh applicators].
    Koch JM; Bornfeld N; Waubke TN; Wessing A
    Fortschr Ophthalmol; 1988; 85(6):642-5. PubMed ID: 3220378
    [No Abstract]   [Full Text] [Related]  

  • 18. A clinicopathological study of seven globes enucleated after primary radiation therapy for malignant melanoma of the choroid or ciliary body.
    Liszauer AD; Brownstein S; Corriveau C; Deschênes J
    Can J Ophthalmol; 1990 Dec; 25(7):340-4. PubMed ID: 2090338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical management of ciliary body melanoma].
    Romanowska-Dixon B
    Klin Oczna; 2005; 107(10-12):627-31. PubMed ID: 16619806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic ophthalmia after ruthenium plaque brachytherapy.
    Ahmad N; Soong TK; Salvi S; Rudle PA; Rennie IG
    Br J Ophthalmol; 2007 Mar; 91(3):399-401. PubMed ID: 17322472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 70.